Different Cutoff Levels of Fecal Calprotectin to Predict Clinical Relapse in Ulcerative Colitis

Inflammatory Bowel Diseases

Volumn 22, Issue 7, 2016, Pages E26-

  Scaioli, Eleonora ^a   Digby, Richard John ^b   Belluzzi, Andrea ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; BIOLOGICAL MARKER;

AREA UNDER THE CURVE; CLINICAL PRACTICE; COLONOSCOPY; FECES ANALYSIS; HUMAN; LETTER; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; REMISSION; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; CHRONIC DISEASE; FECES; RECURRENT DISEASE;

BIOMARKERS; CHRONIC DISEASE; COLITIS, ULCERATIVE; FECES; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; RECURRENCE;

EID: 84976260941     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000839     Document Type: Letter

References (5)

1. Theede K, Holck S, Ibsen P, et al. Fecal calprotectin predicts relapse and histological mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2016;22: 1042-1048
2. Costa F, Mumolo MG, Ceccarelli L, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut. 2005;54: 364-368
3. García-Sánchez V, Iglesias-Flores E, González R, et al. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? J Crohns Colitis. 2010;4:144-152
4. Scaioli E, Scagliarini M, Cardamone C, et al. Clinical application of faecal calprotectin in ulcerative colitis patients. Eur J Gastroenterol Hepatol. 2015; 27:1418-1424
5. Lobatón T, Rodríguez-Moranta F, Lopez A, et al. A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis. Inflamm Bowel Dis. 2013;19:1034-1042